Immunity in atherosclerosis: focusing on T and B cells
AV Poznyak, EE Bezsonov, TV Popkova… - International Journal of …, 2021 - mdpi.com
Atherosclerosis is the major cause of the development of cardiovascular disease, which, in
turn, is one of the leading causes of mortality worldwide. From the point of view of …
turn, is one of the leading causes of mortality worldwide. From the point of view of …
Cryo-EM structure of the human IgM B cell receptor
The B cell receptor (BCR) initiates immune responses through antigen recognition. We
report a 3.3-angstrom cryo–electron microscopy structure of human immunoglobulin M (IgM) …
report a 3.3-angstrom cryo–electron microscopy structure of human immunoglobulin M (IgM) …
Regulation of B-cell receptor signaling and its therapeutic relevance in aggressive B-cell lymphomas
Simple Summary Dysregulated B-cell receptor (BCR) signaling is considered a potent
contributor to tumor survival in different subtypes of B-cell non-Hodgkin lymphomas (B …
contributor to tumor survival in different subtypes of B-cell non-Hodgkin lymphomas (B …
NFKBIE mutations are selected by the tumor microenvironment and contribute to immune escape in chronic lymphocytic leukemia
A Bonato, S Chakraborty, R Bomben, G Canarutto… - Leukemia, 2024 - nature.com
Loss-of-function mutations in NFKBIE, which encodes for the NF-κB inhibitor IκBε, are
frequent in chronic lymphocytic leukemia (CLL) and certain other B-cell malignancies and …
frequent in chronic lymphocytic leukemia (CLL) and certain other B-cell malignancies and …
If small molecules immunotherapy comes, can the prime be far behind?
J Zhang, Y Zhang, B Qu, H Yang, S Hu… - European Journal of …, 2021 - Elsevier
Anti-cancer immunotherapy, which includes cellular immunotherapy, immune checkpoint
inhibitors and cancer vaccines, has transformed the treatment strategies of several …
inhibitors and cancer vaccines, has transformed the treatment strategies of several …
A loss-of-adhesion CRISPR-Cas9 screening platform to identify cell adhesion-regulatory proteins and signaling pathways
MFM de Rooij, YJ Thus, N Swier… - Nature …, 2022 - nature.com
The clinical introduction of the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, which targets
B-cell antigen-receptor (BCR)-controlled integrin-mediated retention of malignant B cells in …
B-cell antigen-receptor (BCR)-controlled integrin-mediated retention of malignant B cells in …
[HTML][HTML] The inositol 5-phosphatase INPP5B regulates B cell receptor clustering and signaling
A Droubi, C Wallis, KE Anderson, S Rahman… - Journal of Cell …, 2022 - rupress.org
Upon antigen binding, the B cell receptor (BCR) undergoes clustering to form a signalosome
that propagates downstream signaling required for normal B cell development and …
that propagates downstream signaling required for normal B cell development and …
Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next?
Simple Summary Since the identification of a large variety of biomarkers in B cell
malignancies as being driving factors for tumor progression and patient prognosis, their …
malignancies as being driving factors for tumor progression and patient prognosis, their …
[HTML][HTML] Does IFITM3 link inflammation to tumorigenesis?
J Lee - Bmb Reports, 2022 - ncbi.nlm.nih.gov
Uncontrolled chronic inflammation, in most cases due to excessive cytokine signaling
through their receptors, is known to contribute to the development of tumorigenesis …
through their receptors, is known to contribute to the development of tumorigenesis …
[HTML][HTML] A role for Hes1 in constraining germinal center B cell formation
Germinal center is a transient lymphoid tissue structure in which B cells undergo affinity
maturation and differentiate into memory B cells and plasma cells. GC formation depends on …
maturation and differentiate into memory B cells and plasma cells. GC formation depends on …